Veradigm | MDRX - Equity Capital And Reserves


Veradigm reported $1.02B in Equity Capital and Reserves for its fiscal quarter ending in December of 2022.





Equity Capital And Reserves Change Date
Alcidion AUD 89.64M 1.84M Dec/2025
Ambu A/S DKK 6.1B 65M Mar/2026
Amplifon EUR 1.08B 78.22M Mar/2026
Cardinal Health USD -2.83B 52M Mar/2026
Centene USD 21.43B 1.47B Mar/2026
Charles River Laboratories USD 2.9B 265.94M Mar/2026
Cigna USD 42.21B 497M Mar/2026
Coloplast 13.8B 2.32B Dec/2025
Computer Programs Systems USD 165.74M 14.62M Dec/2025
Convatec Group USD 1.69B 34M Dec/2024
CVS Health USD 77.46B 2.24B Mar/2026
Diasorin EUR 1.53B 151.64M Jun/2025
Elevance Health USD 43.9B 124M Mar/2026
General Electric Aerospace USD 18.06B 841M Mar/2026
Gulf Medical Proj AED 1.22B 56.38M Dec/2025
Humana USD 18.58B 923M Mar/2026
IQVIA Holdings USD 6.22B 282M Mar/2026
Laboratory Of America USD 8.73B 108.8M Mar/2026
Maximus USD 1.7B 22.85M Mar/2026
McKesson USD -2.17B 874M Mar/2026
Med Life RON 483.77M 18.26M Dec/2025
Molina Healthcare USD 4.08B 11M Mar/2026
Omnicell USD 1.26B 24.82M Mar/2026
Oriola-kd EUR 92.8M 8M Mar/2026
Owens Minor USD -464.76M 3.79M Mar/2026
Quest Diagnostics USD 7.37B 196M Mar/2026
Rede D'or Sao Luiz BRL 22.34B 2.98B Mar/2026
Siemens Healthineers EUR 18.21B 217M Mar/2026
Sonova Holding CHF 2.66B 374.5M Jun/2025
Supermax Corporation Bhd MYR 3.77B 44.17M Mar/2026
UnitedHealth USD 101.7B 4.12B Dec/2025
Veeva Systems USD 7.3B 89.6M Mar/2026
Veradigm USD 1.02B 159.52M Dec/2022
Xerox USD 299M 145M Mar/2026